Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful weapon in the fight against high-grade gliomas, a highly invasive cancer that sends cancerous cells throughout the brain and spinal cord. Chlorotoxin binds specifically to tumor cells–but not normal cells.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • There are nearly 14.5 million people in the U.S. living with a history of cancer.  
  • According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. …  
  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…  
  • Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.  
  • Investments in research since the 1970s have generated $1.9 trillion of value to society overall.